Search Results - "AVULA, Rajeswari"

Analysis of Cell-Free DNA to Assess Risk of Tumoremia Following Endoscopic Ultrasound Fine-Needle Aspiration of Pancreatic Adenocarcinomas by Levy, Michael J., Kipp, Benjamin R., Milosevic, Dragana, Schneider, Amber R., Voss, Jesse S., Avula, Rajeswari, Kerr, Sarah E., Henry, Michael R., Highsmith, Edward, Liu, Minetta C., Gleeson, Ferga C.

“…Cellular and nuclear material from tumors disseminates into the bloodstream (tumoremia), but it is not clear whether medical procedures cause release of this…”
Get full text

Loss of HSulf-1 Up-regulates Heparin-binding Growth Factor Signaling in Cancer by Lai, Jinping, Chien, Jeremy, Staub, Julie, Avula, Rajeswari, Greene, Eddie L, Matthews, Tori A, Smith, David I, Kaufmann, Scott H, Roberts, Lewis R, Shridhar, Viji

“…Emerging data suggest that signaling by heparin-binding growth factors is influenced by the sulfation state of N -acetylglucosamine residues of heparan sulfate…”
Get full text

Alternative method of allelic discrimination by Avula, Rajeswari, O'Kane, Dennis, Black, 3rd, John L

“…5' nuclease assays for allelic discrimination use both a wild-type and a mutant probe. Here we present a new method for genotyping by 5' nuclease assays that…”
Get full text

Epigenetic silencing of TCEAL7 (Bex4) in ovarian cancer by CHIEN, Jeremy, STAUB, Julie, AVULA, Rajeswari, HEYU ZHANG, WANGUO LIU, HARTMANN, Lynn C, KAUFMANN, Scott H, SMITH, David I, SHRIDHAR, Viji

“…Epigenetic silencing by hypermethylation of CpGs represents a mechanism of inactivation of tumor suppressors. Here we report on the cloning of a novel…”
Get full text

Studies of Humoral Immunity to Preprohypocretin in Human Leukocyte Antigen DQB10602–Positive Narcoleptic Subjects with Cataplexy by Black, John L., Silber, Michael H., Krahn, Lois E., Avula, Rajeswari K., Walker, Denise L., Pankratz, V. Shane, Fredrickson, Paul A., Slocumb, Nancy L.

“…Canine models for narcolepsy have mutations of the hypocretin receptor 2 gene, and preprohypocretin knockout murine lines exhibit narcoleptic-like behaviors…”
Get full text

A PRAGMATIC TRIAL EVALUATING THE IMPACT OF THE ANUMANA CLINICAL DECISION SUPPORT TOOL FOR GUIDELINE-DIRECTED MEDICAL THERAPY OF HEART FAILURE (ACT-HF): STUDY DESIGN AND METHODS by Lopez-Jimenez, Francisco, Alger, Heather, Avula, Rajeswari, Barry, Barbara, Chatterjee, Ranee, Chow, Chen Hoe, Dolor, Rowena, Greene, Stephen, Gundurao, Vinay, Hackett, Sarah, Kumar-M, Praveen, Lin, Grace, Mehta, Ketan, Puranik, Arjun, Rushlow, David, Stampehl, Mark, Awasthi, Samir

Get full text

A MULTICENTER PRAGMATIC IMPLEMENTATION STUDY OF AI-ECG-BASED CLINICAL DECISION SUPPORT SOFTWARE TO IDENTIFY LOW LVEF (AIM ECG-AI): STUDY DESIGN AND METHODS by Lopez-Jimenez, Francisco, Alger, Heather, Avula, Rajeswari, Barry, Barbara, Chatterjee, Ranee, Broyles, Damon, Dolor, Rowena, Frisch, Daniel R., Greene, Stephen, Gundurao, Vinay, Hackett, Sarah, Jain, Prerak, Mehta, Ketan, Pandey, Ambarish, Ranganathan, Mohan Krishna, Rushlow, David, Stampehl, Mark, Steinberg, Benjamin Adam, Awasthi, Samir

Get full text

Sa1691 – Prospective Evaluation of the Clinical Impact of Hematogenous Tumor Seeding (Tumoremia) Following Eus Fna of Primary Pancreatic Ductal Adenocarcinoma by Levy, Michael J., Kipp, Benjamin R., Schneider, Amber, Bridgeman, Amber, Milosevic, Dragana, Voss, Jesse, Avula, Rajeswari, Kerr, Sarah, Henry, Michael, Liu, Minetta, Gleeson, Ferga C.

Get full text

Sa1981 - Prospective Cell Free DNA Assessment of the Risk of Tumor Seeding Following Primary Tumor EUS FNA with Concomitant Peripheral Blood, Portal Vein, and Hepatic Vein FNA Assessment by Levy, Michael J., Kipp, Benjamin R., Milosevic, Dragana, Schneider, Amber, Voss, Jesse, Avula, Rajeswari, Kerr, Sarah, Henry, Michael, Highsmith, W. Edward, Liu, Minetta, Gleeson, Ferga C.

Get full text

Su1318 - Prospective Molecular Assessment of Kras Mutation Concordance Rate Between Peripheral Blood and Primary Tumor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing EUS FNA by Levy, Michael J., Kipp, Benjamin R., Milosevic, Dragana, Schneider, Amber, Voss, Jesse, Avula, Rajeswari, Kerr, Sarah, Henry, Michael, Highsmith, W. Edward, Liu, Minetta, Gleeson, Ferga C.

Get full text

Su1371 PROSPECTIVE EVALUATION OF CLINICAL, LABORATORY, AND TUMOR-RELATED CHARACTERISTICS ASSOCIATED WITH HEMATOGENOUS TUMOR SEEDING FOLLOWING EUS FNA OF PANCREATIC DUCTAL ADENOCARCINOMA by Levy, Michael J., Kipp, Benjamin R., Milosevic, Dragana, Schneider, Amber, Voss, Jesse, Avula, Rajeswari, Kerr, Sarah, Henry, Michael, Highsmith, W. Edward, Liu, Minetta, Gleeson, Ferga C.

Get full text

Concordance between predicted HLA type using next generation sequencing data generated for non-HLA purposes and clinical HLA type by Moyer, Ann M., Dukek, Brian, Duellman, Patti, Schneider, Brittany, Wakefield, Laurie, Skierka, Jennifer M., Avula, Rajeswari, Bhagwate, Aditya V., Kalari, Krishna R., Kreuter, Justin D., Goetz, Matthew P., Boughey, Judy C., Black, John L., Gandhi, Manish J.

“…We explored the feasibility of obtaining accurate HLA type using pre-existing NGS data not generated for HLA purposes. 83 exomes and 500 targeted NGS…”
Get full text

Technical Advances for the Clinical Genomic Evaluation of Sudden Cardiac Death: Verification of Next-Generation Sequencing Panels for Hereditary Cardiovascular Conditions Using Formalin-Fixed Paraffin-Embedded Tissues and Dried Blood Spots by Baudhuin, Linnea M, Leduc, Charles, Train, Laura J, Avula, Rajeswari, Kluge, Michelle L, Kotzer, Katrina E, Lin, Peter T, Ackerman, Michael J, Maleszewski, Joseph J

“…Postmortem genetic testing for heritable cardiovascular (CV) disorders is often lacking because ideal specimens (ie, whole blood) are not retained routinely at…”
Get full text

Technical Advances for the Clinical Genomic Evaluation of Sudden Cardiac Death by Baudhuin, Linnea M, Leduc, Charles, Train, Laura J, Avula Rajeswari, Kluge, Michelle L, Kotzer, Katrina E, Lin, Peter T, Ackerman, Michael J, Maleszewski, Joseph J

“…Background—Postmortem genetic testing for heritable cardiovascular (CV) disorders is often lacking because ideal specimens (ie, whole blood) are not retained…”
Get full text

Abstract 505: Optimized 7-Plex cell-free DNA assay for clinically relevant KRAS mutations in colorectal cancer by Avula, Rajeswari, Kipp, Benjamin R., Voss, Jesse S., Haselkorn, Keegan E., Highsmith, W. Edward, Halling, Kevin C., Jones, Jeremy C., Alberts, Steven R., Campion, Michael B., Nelson, Cassandra J., Jen, Jin, Wieben, Eric D., Cunningham, Julie M., Liu, Minetta C.

“…Abstract Background: KRAS gene mutations are present in approximately 40% of colorectal adenocarcinomas and predict for nonresponse to the anti-epidermal…”
Get full text

SULT1A1, CYP2C19 and disease-free survival in early breast cancer patients receiving tamoxifen by Moyer, Ann M, Suman, Vera J, Weinshilboum, Richard M, Avula, Rajeswari, Black, John L, Safgren, Stephanie L, Kuffel, Mary J, Ames, Matthew M, Ingle, James N, Goetz, Matthew P

“…Tamoxifen biotransformation to endoxifen, a potent antiestrogen, is catalyzed by CYP2D6. In addition, CYP2C19 and SULT1A1 have also been implicated in the…”
Get more information

Genetic analysis of early- versus late-stage ovarian tumors by SHRIDHAR, Viji, LEE, John, KEENEY, Gary, ROCHE, Patrick, CLIBY, William, LU, Karen, SCHMANDT, Rosemarie, MILLS, Gordon B, BAST, Robert C, JAMES, C. David, COUCH, Fergus J, HARTMANN, Lynn C, PANDITA, Ajay, LILLIE, Jim, SMITH, David I, ITURRIA, Steve, AVULA, Rajeswari, STAUB, Julie, MORRISSEY, Mike, CALHOUN, Eric, AMI SEN, KALLI, Kimberly

“…In the United States, ovarian cancer is the fourth most common cause of cancer-related deaths among women. The most important prognostic factor for this cancer…”
Get full text

Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization by SHRIDHAR, Viji, AMI SEN, CHIEN, Jeremy, STAUB, Julie, AVULA, Rajeswari, KOVATS, Steve, LEE, John, LILLIE, Jim, SMITH, David I

“…To identify novel tumor suppressor genes involved in ovarian carcinogenesis, we generated four down-regulated suppression subtraction cDNA libraries from two…”
Get full text

Analysis of hypocretin (orexin) antibodies in patients with narcolepsy by BLACK, John L, SILBER, Michael H, KRAHN, Lois E, FREDRICKSON, Paul A, PANKRATZ, V. Shane, AVULA, Rajeswari, WALKER, Denise L, SLOCUMB, Nancy L

“…We tested the hypothesis that patients with narcolepsy have serum antibodies specific for preprohypocretin and its derivatives. We tested sera from strictly…”
Get full text

Correlation of CYP2B6 , CYP2C19 , ABCC4 and SOD2 genotype with outcomes in allogeneic blood and marrow transplant patients by Black, John L, Litzow, Mark R, Hogan, William J, O’Kane, Dennis J, Walker, Denise L, Lesnick, Timothy G, Kremers, Walter K, Avula, Rajeswari, Ketterling, Rhett P

“…Abstract CYP2B6 , CYP2C19 , ABCC4 , and SOD2 have been implicated in adverse drug reactions and survival after cyclophosphamide (CPA) treatment. 110 BMT…”
Get full text